Delivery Order SPE2DR25D2001-SPE2DR26FBFQ8
- Not listed
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL injections. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition, with performance scheduled for completion by December 1, 2025, and fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,164.65 to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This is a firm fixed-price delivery order issued on December 8, 2025, with an ultimate completion date of December 30, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,951.86 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injections. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. The contract is non-set-aside and competitively awarded, with performance of work taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,616.51 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This is a firm fixed price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of May 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,329.32 for Somatuline Depot 120 mg/0.5 ml pharmaceutical product on December 1, 2025, with completion expected by December 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,807.44 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract utilizes firm fixed-price pricing with a completion date of October 15, 2025, and carries no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $19,759.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. This competitive award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $24,987.96 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and was awarded on December 12, 2025, without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $5,918.93 to AmerisourceBergen Drug Corp for Somatuline Depot 90 mg/0.3 ml, a specialized pharmaceutical product used in endocrinology and oncology treatment. This firm fixed-price delivery order, issued on December 8, 2025, with completion targeted for December 30, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFQ8Delivery Order
The Defense Logistics Agency awarded a $5,918.93 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injections, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's $999,999,999.00 IDC with DLA Troop Support Medical running through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to federal agencies including the Defense Health Agency and U.S. Coast Guard. Somatuline Depot is a specialty medication used in endocrine and oncology treatments, reflecting the company's role in delivering specialized pharmaceutical commodities to support federal medical supply chain requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/25/25 |